share_log

Need To Know: Analysts Just Made A Substantial Cut To Their Nanofilm Technologies International Limited (SGX:MZH) Estimates

Need To Know: Analysts Just Made A Substantial Cut To Their Nanofilm Technologies International Limited (SGX:MZH) Estimates

需要知道:分析師剛剛對他們的納米薄膜技術國際有限公司(SGX:MZH)的估計進行了大幅削減
Simply Wall St ·  2023/02/27 08:21

The analysts covering Nanofilm Technologies International Limited (SGX:MZH) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Both revenue and earnings per share (EPS) estimates were cut sharply as analysts factored in the latest outlook for the business, concluding that they were too optimistic previously. Surprisingly the share price has been buoyant, rising 15% to S$1.50 in the past 7 days. It will be interesting to see if the downgrade has an impact on buying demand for the company's shares.

分析師涵蓋 納米科技國際有限公司 SGX:MZH)今天對股東的法定預測進行了大幅修訂,對今年的法定預測進行了大量的負面影響。由於分析師考慮了該業務的最新展望,因此每股收入和每股收益(EPS)的估計都大幅減少,得出結論是以前過於樂觀。令人驚訝的是,股價一直在浮動,在過去 7 天內上漲了 15%,達到 1.50 新元。看看降級是否對公司股票的購買需求產生影響將會很有趣。

Following the downgrade, the most recent consensus for Nanofilm Technologies International from its eight analysts is for revenues of S$266m in 2023 which, if met, would be a decent 12% increase on its sales over the past 12 months. Statutory earnings per share are presumed to swell 17% to S$0.078. Previously, the analysts had been modelling revenues of S$298m and earnings per share (EPS) of S$0.098 in 2023. Indeed, we can see that the analysts are a lot more bearish about Nanofilm Technologies International's prospects, administering a substantial drop in revenue estimates and slashing their EPS estimates to boot.

在降級之後,其八位分析師對納米技術國際最近的共識是 2023 年 26 億新加坡元的收入,如果滿足,在過去 12 個月內,其銷售額將大幅增加 12%。法定每股盈利被推定為增幅 17% 至 0.078 新加坡元。此前,分析師在 2023 年建模了 298 億新加坡元的收入和每股盈利 0.098 新加坡元。事實上,我們可以看到,分析師對 Nanofilm Technologies 國際的前景更加看跌,因此收入估計大幅下降,並削減了他們的每股收益估計。

See our latest analysis for Nanofilm Technologies International

查看我們對國際奈米薄膜技術的最新分析

earnings-and-revenue-growth
SGX:MZH Earnings and Revenue Growth February 27th 2023
新加坡:MZH 2023 年 2 月 27 日盈利和收入增長

It'll come as no surprise then, to learn that the analysts have cut their price target 17% to S$1.40. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Nanofilm Technologies International at S$2.20 per share, while the most bearish prices it at S$1.20. This is a fairly broad spread of estimates, suggesting that the analysts are forecasting a wide range of possible outcomes for the business.

得知分析師已將其目標價格降至 17% 至 1.40 新元,這將毫不奇怪。但是,還有另一種方法可以考慮價格目標,那就是查看分析師提出的價格目標範圍,因為廣泛的估計可能會暗示對業務可能的結果有多種不同的看法。目前,最看漲的分析師將納米技術國際評價為每股 2.20 新元,而最看跌的價格為 1.20 新元。這是估計的一個相當廣泛的傳播,這表明分析師正在預測廣泛的業務可能的結果。

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. It's pretty clear that there is an expectation that Nanofilm Technologies International's revenue growth will slow down substantially, with revenues to the end of 2023 expected to display 12% growth on an annualised basis. This is compared to a historical growth rate of 17% over the past five years. Compare this to the 9 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 11% per year. Factoring in the forecast slowdown in growth, it looks like Nanofilm Technologies International is forecast to grow at about the same rate as the wider industry.

獲得更多關於這些預測的背景資料的一種方法是看看它們與過去的表現如何比較,以及同一行業中的其他公司的表現如何。很明顯,人們預計納米技術國際的收入增長將大幅放緩,截至 2023 年底的收入預計將以年度計算增長 12%。這與過去五年的 17% 相比,歷史增長率為 17%。與該行業擁有分析師覆蓋率的 9 家其他公司進行比較,這些公司預計將以每年 11% 的速度增長其收入。考慮預測增長放緩,看起來納米膜技術國際預計將以與更廣泛的行業大致相同的速度增長。

The Bottom Line

底線

The most important thing to take away is that analysts cut their earnings per share estimates, expecting a clear decline in business conditions. Lamentably, they also downgraded their sales forecasts, but the business is still expected to grow at roughly the same rate as the market itself. Given the scope of the downgrades, it would not be a surprise to see the market become more wary of the business.

要帶走的最重要的事情是,分析師削減了他們的每股收益估計,預計業務條件明顯下降。可悲的是,他們還降級了銷售預測,但是預計該業務仍將以與市場本身大致相同的速度增長。鑑於降級的範圍,看到市場對業務更加警惕並不令人意外。

Still, the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Nanofilm Technologies International going out to 2025, and you can see them free on our platform here.

儘管如此,該業務的長期前景比明年的收益更加相關。在 Simply Wall St,我們為 2025 年的納米薄膜技術國際提供了全面的分析師估計,您可以在我們的平台上免費看到它們,請點擊這裡。

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies that insiders are buying.

另一種方法來尋找有趣的公司,可能是 到達一個拐點 是跟踪管理層是否購買或出售,與我們 自由 內部人士正在購買的成長公司名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?關注內容? 取得聯繫 直接與我們聯繫。 或者,通過電子郵件發送電子郵件給編輯團隊。
這篇文章由簡單牆聖是一般性質. 我們僅使用公正的方法,根據歷史數據和分析師預測提供評論,我們的文章並不打算作為財務建議。 它並不構成購買或出售任何股票的建議,也不會考慮您的目標或您的財務狀況。我們的目標是為您帶來由基本數據驅動的長期集中分析。請注意,我們的分析可能不會考慮最新的價格敏感公司公告或定性材料。簡易華街在提及的任何股票中都沒有倉位。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論